Alexander Azoy's Net Worth
$577 Thousand
Who is Alexander Azoy?
Alexander Azoy does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Unity Biotechnology, Inc., Sienna Biopharmaceuticals, Inc., and Arcus Biosciences, Inc..
SEC CIK
Alexander Azoy's CIK is 0001771961
Past Insider Trading and Trends
2019 was Alexander Azoy's most active year for acquiring shares with 8 total transactions. Alexander Azoy's most active month to acquire stocks was the month of July. 2019 was Alexander Azoy's most active year for disposing of shares, totalling 7 transactions. Alexander Azoy's most active month to dispose stocks was the month of July. 2020 saw Alexander Azoy paying a total of $0.00 for 135,000 shares, this is the most they've acquired in one year. In 2023 Alexander Azoy cashed out on 2,676 shares for a total of $49,666.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Unity Biotechnology, Inc. (UBX) Snapshot price: $1.52
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 135K |
—
|
—
| 135K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sienna Biopharmaceuticals, Inc. No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.26% | -2.40K |
$0.23 | -$551.08 | 103.55K |
Oct 2
| |||
Form 4
| +194.73% | 70K |
—
|
—
| 105.95K |
Aug 6
| |||
Form 4
| -4.14% | -1.55K |
$0.76 | -$1,179.52 | 35.95K |
Jul 2
| |||
Form 4
| +114.29% | 20K |
—
|
—
| 37.5K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arcus Biosciences, Inc. (RCUS) Snapshot price: $15.72
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.64% | -1.36K |
$14.97 | -$20,314.29 | 19.07K |
Scheduled
|
Aug 13
| ||
Form 4
| +86.59% | 8.85K |
—
|
—
| 19.07K |
Jan 23
| |||
Form 4
| -0.66% | -68.00 |
$18.21 | -$1,238.28 | 10.22K |
Scheduled
|
Dec 20
| ||
Form 4
| -11.28% | -1.31K |
$17.92 | -$23,435.27 | 10.29K |
Scheduled
|
Dec 18 - Dec 19
| ||
Form 4
| -2.37% | -282.00 |
$14.95 | -$4,215.90 | 11.6K |
Scheduled
|
Dec 1
| ||
Form 4
| -8.07% | -1.02K |
$20.41 | -$20,777.38 | 11.6K |
Jul 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||